{"entities":{"Q9627":{"pageid":13788,"ns":120,"title":"Item:Q9627","lastrevid":205550,"modified":"2020-05-21T15:39:08Z","type":"item","id":"Q9627","labels":{"en":{"language":"en","value":"Giulino-Roth L, et al. Mol. cancer therapeutics (2017) cited as Ref 364 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9627$2A08E3A1-FCF0-4BCE-AD42-0E7D86142631","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9627$726D9E22-16CD-4A48-95EC-6C589FADEA70","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"Giulino-Roth L","type":"string"},"datatype":"string"},"type":"statement","id":"Q9627$82F4414E-1183-49C9-A0B5-EFDC69986E81","rank":"normal"}],"P138":[{"mainsnak":{"snaktype":"value","property":"P138","datavalue":{"value":"10.1158/1535-7163.MCT-16-0848","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9627$C5A36A9E-87CA-4642-8679-1D9D8EE17C4F","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2017-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9627$4D49C9BC-0C37-485D-9106-23C34CE39B8D","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"Mol. cancer therapeutics","type":"string"},"datatype":"string"},"type":"statement","id":"Q9627$96CA10AC-1BE0-4A14-8454-03ED3C144066","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"16","type":"string"},"datatype":"string"},"type":"statement","id":"Q9627$DB4BBF5D-F297-43BA-A8F0-2FC4BBC48ADA","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"Inhibition of Hsp90 suppresses PI3K/AKT/mTOR signaling and has antitumor activity in Burkitt lymphoma","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9627$D4170B0B-B848-43C8-94CE-CFBFE8C9F499","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"1779-1790","type":"string"},"datatype":"string"},"type":"statement","id":"Q9627$D338B08D-1ED6-4353-864C-A6BD94970AF4","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"Giulino-Roth L, et al. Mol. cancer therapeutics (2017) cited as Ref 364 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/Giulino-Roth_L,_et_al._Mol._cancer_therapeutics_(2017)_cited_as_Ref_364_in_DOI:_10.1038/s41392-020-0110-5"}}}}}